Filing Details
- Accession Number:
- 0001127602-19-009111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 11:22:55
- Reporting Period:
- 2019-02-27
- Accepted Time:
- 2019-03-01 11:22:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-27 | 144 | $142.45 | 279,569 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-27 | 200 | $142.49 | 279,369 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-27 | 169 | $142.51 | 279,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 18,390 | Indirect | 2017 GRAT |
| Common Stock | 25,000 | Indirect | 2018 GRAT |
| Common Stock | 340 | Indirect | By Trust |
| Common Stock | 10,000 | Indirect | Held By Spouse |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.
Billionaire Hedge Funds
